Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box–Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and In Vivo Assessment

• Md. Ali Mujtaba,
• Mohammed Kaleem,
• Ragini Chaware,
• Ashwini Ingole,
• Yahya I. Asiri,
• Mohd. Zaheen Hassan,
• Vidya Sabale,
• Prafulla Sabale,
• Md. Khalid Anwer,
• Danish Mahmood,
• Mohammed F. Aldawsari

Affiliations

Md. Ali Mujtaba

Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Arar, Saudi Arabia

Mohammed Kaleem

Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University Nagpur, Nagpur, Maharashtra, India

Ragini Chaware

Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University Nagpur, Nagpur, Maharashtra, India

Ashwini Ingole

Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University Nagpur, Nagpur, Maharashtra, India

Yahya I. Asiri

Department of Pharmacology, College of Pharmacy, King Khalid University, Asir, Saudi Arabia

Mohd. Zaheen Hassan

Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Asir, Saudi Arabia

Vidya Sabale

Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University Nagpur, Nagpur, Maharashtra, India

Prafulla Sabale

Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India

Md. Khalid Anwer

Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia

Danish Mahmood

Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia

Mohammed F. Aldawsari

Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia